No abstract available
MeSH terms
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents / therapeutic use*
-
Antineoplastic Agents, Phytogenic / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Carcinoma, Non-Small-Cell Lung / drug therapy*
-
Carcinoma, Non-Small-Cell Lung / pathology
-
Cetuximab
-
Cisplatin / administration & dosage
-
Clinical Trials, Phase III as Topic
-
Dose-Response Relationship, Drug
-
Epidermal Growth Factor / metabolism
-
ErbB Receptors / antagonists & inhibitors
-
Follow-Up Studies
-
Humans
-
Lung Neoplasms / drug therapy*
-
Lung Neoplasms / pathology
-
Proportional Hazards Models
-
Survival Analysis
-
Time Factors
-
Treatment Outcome
-
Vinblastine / administration & dosage
-
Vinblastine / analogs & derivatives
-
Vinorelbine
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents
-
Antineoplastic Agents, Phytogenic
-
Vinblastine
-
Epidermal Growth Factor
-
ErbB Receptors
-
Cetuximab
-
Cisplatin
-
Vinorelbine